Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
Seven is facing another workplace lawsuit by a former journalist, with former Spotlight reporter Amelia Saw accusing the TV network of general protections breaches under the Fair Work Act.
Medical device supplier Medtronic has been socked with a $22 million penalty after it supplied non-compliant bone graft kits to hospitals, in what is the largest penalty under the Therapeutics Good Act.
A second law firm has filed a class action against Harvey Norman alleging it sold extended warranties to customers that had “no real value”.
Insurers have won a challenge to a declaration that engineering firm CIMIC could make claims under policies for costs arising from corruption cases, including a $32 million class action settlement.
Two failed shareholder class actions against the Commonwealth Bank of Australia want to delay paying the bank’s costs until after their 62-ground appeal is heard.
Cosmetics maker Self Care has won its case against companies with ties to China that were found to have sold counterfeit versions of its popular Freezeframe anti-ageing creams.
Private equity firm Alceon and a vendor have been hit with $3 million damages over the misleading sale of a Queensland shopping centre for $55 million.
An appeals court has dismissed a class action on behalf of small businesses over alleged nuisance caused by the construction of Sydney’s $3 billion light rail network.
A judge has tossed ASIC’s case against REST over alleged misleading representations, finding the representations were statements of opinion reasonably held based on the advice of lawyers.